NM_005529.7:c.575-86G>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005529.7(HSPG2):​c.575-86G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.239 in 1,573,620 control chromosomes in the GnomAD database, including 49,129 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 5634 hom., cov: 32)
Exomes 𝑓: 0.24 ( 43495 hom. )

Consequence

HSPG2
NM_005529.7 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.241

Publications

8 publications found
Variant links:
Genes affected
HSPG2 (HGNC:5273): (heparan sulfate proteoglycan 2) This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and transthyretin, etc., and it plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and tardive dyskinesia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
HSPG2 Gene-Disease associations (from GenCC):
  • Schwartz-Jampel syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Silverman-Handmaker type dyssegmental dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • Schwartz-Jampel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 1-21888152-C-A is Benign according to our data. Variant chr1-21888152-C-A is described in ClinVar as Benign. ClinVar VariationId is 1268753.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.57 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HSPG2NM_005529.7 linkc.575-86G>T intron_variant Intron 6 of 96 ENST00000374695.8 NP_005520.4 P98160

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HSPG2ENST00000374695.8 linkc.575-86G>T intron_variant Intron 6 of 96 1 NM_005529.7 ENSP00000363827.3 P98160
HSPG2ENST00000374673.4 linkc.380-86G>T intron_variant Intron 4 of 6 3 ENSP00000497688.1 A0A3B3IT11
HSPG2ENST00000412328.5 linkn.343-86G>T intron_variant Intron 3 of 5 2

Frequencies

GnomAD3 genomes
AF:
0.258
AC:
39169
AN:
152004
Hom.:
5633
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.262
Gnomad AMI
AF:
0.253
Gnomad AMR
AF:
0.361
Gnomad ASJ
AF:
0.126
Gnomad EAS
AF:
0.589
Gnomad SAS
AF:
0.249
Gnomad FIN
AF:
0.215
Gnomad MID
AF:
0.133
Gnomad NFE
AF:
0.222
Gnomad OTH
AF:
0.254
GnomAD4 exome
AF:
0.237
AC:
336498
AN:
1421498
Hom.:
43495
AF XY:
0.236
AC XY:
166674
AN XY:
707414
show subpopulations
African (AFR)
AF:
0.257
AC:
8426
AN:
32776
American (AMR)
AF:
0.424
AC:
18265
AN:
43080
Ashkenazi Jewish (ASJ)
AF:
0.133
AC:
3411
AN:
25704
East Asian (EAS)
AF:
0.554
AC:
21737
AN:
39210
South Asian (SAS)
AF:
0.253
AC:
21453
AN:
84676
European-Finnish (FIN)
AF:
0.220
AC:
9734
AN:
44300
Middle Eastern (MID)
AF:
0.188
AC:
794
AN:
4222
European-Non Finnish (NFE)
AF:
0.219
AC:
238187
AN:
1088484
Other (OTH)
AF:
0.245
AC:
14491
AN:
59046
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
13259
26518
39778
53037
66296
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8458
16916
25374
33832
42290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.258
AC:
39191
AN:
152122
Hom.:
5634
Cov.:
32
AF XY:
0.262
AC XY:
19503
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.262
AC:
10854
AN:
41492
American (AMR)
AF:
0.361
AC:
5526
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.126
AC:
439
AN:
3472
East Asian (EAS)
AF:
0.588
AC:
3033
AN:
5160
South Asian (SAS)
AF:
0.250
AC:
1204
AN:
4820
European-Finnish (FIN)
AF:
0.215
AC:
2275
AN:
10594
Middle Eastern (MID)
AF:
0.133
AC:
39
AN:
294
European-Non Finnish (NFE)
AF:
0.221
AC:
15056
AN:
67974
Other (OTH)
AF:
0.253
AC:
534
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1442
2884
4327
5769
7211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
402
804
1206
1608
2010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.229
Hom.:
498
Bravo
AF:
0.266
Asia WGS
AF:
0.372
AC:
1295
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
1.5
DANN
Benign
0.62
PhyloP100
-0.24
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3767140; hg19: chr1-22214645; API